NACDS Backs Conditional Federal Pseudoephedrine Behind-The-Counter Bill
This article was originally published in The Tan Sheet
Executive Summary
Inconsistency among states' authority over controlled substances scheduling is the crux of current debate over a federal pseudoephedrine control bill